Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where S Salemi is active.

Publication


Featured researches published by S Salemi.


Clinical Transplantation | 2010

MR cholangiography in orthotopic liver transplantation: sensitivity and specificity in detecting biliary complications

Piero Boraschi; Francescamaria Donati; R Gigoni; Alessia Volpi; S Salemi; Franco Filipponi; Fabio Falaschi

Boraschi P, Donati F, Gigoni R, Volpi A, Salemi S, Filipponi F, Falaschi F. MR cholangiography in orthotopic liver transplantation: sensitivity and specificity in detecting biliary complications.
Clin Transplant 2010: 24: E82–E87.
© 2009 John Wiley & Sons A/S.


European Journal of Radiology | 2010

Secretin-stimulated MR cholangio-pancreatography in the evaluation of asymptomatic patients with non-specific pancreatic hyperenzymemia

Francescamaria Donati; Piero Boraschi; R Gigoni; S Salemi; Lorenzo Faggioni; Cristina Bertucci; Claudia Cecchi; Carlo Bartolozzi; Fabio Falaschi

PURPOSE To assess the diagnostic value of secretin-stimulated MRCP (SS-MRCP) compared with conventional MRCP in asymptomatic patients with mild elevations of pancreatic enzymes. MATERIALS AND METHODS Eighty asymptomatic patients with pancreatic hyperenzymemia underwent MR imaging at 1.5T-device (Signa EXCITE, GE Healthcare). After the acquisition of axial T1w,T2w sequences, and conventional MRCP, SS-MRCP was performed using a single-slice coronal breath-hold, thick-slab, SSFSE T2w sequence, repeated every 30s up to 15 min following intravenous injection of secretin (Secrelux, Sanochemia). RESULTS On the basis of the standards of reference, our final diagnoses were: negative findings (n=23), pancreas divisum (n=22), mild chronic pancreatitis (n=14), inflammatory ampullary stenosis (n=3), juxtapapillary duodenal diverticulum (n=1), small cystic lesions (<1cm) (n=22; 5/22 cases associated with pancreas divisum). The image quality of SS-MRCP was significantly higher than that of conventional MRCP (p<0.0001). Standards of reference did not differ significantly from of SS-MRCP findings (p=0.5), while was statistically different from those of conventional MRCP (p<0.0001). A significant difference was found between conventional MRCP and SS-MRCP findings (p<0.0001). CONCLUSION In asymptomatic patients with non-specific pancreatic hyperenzymemia SS-MRCP may represent the best non-invasive diagnostic technique, since it gives morphological and functional information.


Magnetic Resonance Imaging | 2013

Focal nodular hyperplasia of the liver: diffusion and perfusion MRI characteristics

Francescamaria Donati; Piero Boraschi; R Gigoni; S Salemi; Fabio Falaschi; Carlo Bartolozzi

PURPOSE To present diffusion and perfusion magnetic resonance imaging (MRI) characteristics of focal nodular hyperplasia (FNH) of the liver. MATERIALS AND METHODS Thirty-five patients with 52 FNHs (21 were pathologically-confirmed) underwent MRI at 1.5-T device. MR diffusion [diffusion-weighted imaging (DWI)] was performed using a free-breathing single-shot, spin-echo, echo-planar sequence with b gradient factor value of 500 s/mm². MR perfusion [perfusion-weighted imaging (PWI)] consisted of a 3D free-breathing LAVA sequence repeated up to 5 minutes after injection of 7 mL Gd-BOPTA (MultiHance, Bracco, Italy) and 20 mL saline flush at a flow rate of 4 mL/s. Apparent diffusion coefficient (ADC) and time-signal intensity curve (TSIC) were obtained for both normal liver and each FNH by two reviewers in conference; maximum enhancement (ME) percentage, time to peak enhancement (TTP), and maximal slope (MS) were also calculated. RESULTS On DWI mean ADC value was 1.624×10(-3) mm(2)/s for normal liver and 1.629×10(-3) mm(2)/s for FNH. ADC value for each FNH and the normal liver was not statistically different (P=.936). On PWI, TSIC-Type 1 (quick and marked enhancement and quick decay followed by slowly decaying) was observed in all 52 FNHs, and TSIC-Type 2 (fast enhancement followed by slowly decaying plateau) in all normal livers. The mean ME, TTP and MS values were significantly different for FNH and normal liver (P=.005). CONCLUSION FNHs of the liver showed typical diffusion and perfusion MRI characteristics in all cases. On the ADC map, we could get similar value between the FNHs and the background parenchyma. On the perfusion imaging, FNHs showed a different pattern distinguished from the background liver.


Archive | 2010

MRA in Liver and in Orthotopic Liver Transplants

Piero Boraschi; Francescamaria Donati; S Salemi; F Turini

MR imaging provides the necessary information about variations in the vascular and biliary anatomy and allows evaluation of the hepatic parenchyma for diffuse or focal abnormalities.


Digestive and Liver Disease | 2009

Secretin-stimulated multi-detector CT versus mangafodipir trisodium-enhanced MR imaging plus MRCP in characterization of non-metastatic solid pancreatic lesions

Piero Boraschi; Francescamaria Donati; R Gigoni; S Salemi; Lorenzo Faggioni; M Del Chiaro; Ugo Boggi; Carlo Bartolozzi; Fabio Falaschi

BACKGROUND AND AIM Our study was aimed to compare multiphasic multi-detector computed tomography after secretin stimulation and mangafodipir trisodium-enhanced magnetic resonance imaging plus MR cholangiopancreatography in the characterization of solid pancreatic lesions. PATIENTS AND METHODS Forty patients with ultrasound diagnosis of solid pancreatic lesion prospectively underwent both multi-detector computed tomography and magnetic resonance imaging. Three minutes after intravenous administration of secretin, post-contrast computed tomography scans were performed 40, 80, and 180 s after contrast medium injection. MR protocol included axial/coronal, thin/thick-slab, single-shot T2 w sequences and axial/coronal T1 w breath-hold spoiled gradient-echo images before and 30-40 min after intravenous infusion of manganese dipyri-doxal diphosphate. Different observers blindly evaluated the ability of computed tomography and magnetic resonance imaging to characterize focal pancreatic lesions. Surgery, biopsy, and/or follow-up were considered as our diagnostic gold standard. RESULTS Thirty-five focal pancreatic lesions (adenocarcinoma, n=18; focal chronic pancreatitis, n=4; endocrine tumor, n=6; metastasis, n=1; cystic tumor, n=3; indeterminate cystic lesions, n=3) were present in 34 patients since the remaining 6 subjects showed no pathological finding. Both multi-detector computed tomography and magnetic resonance imaging showed a statistically significant correlation with the gold standard and between themselves in the characterization of 29 solid lesions of the pancreas (p<0.05). CONCLUSION Both imaging techniques well correlate to final diagnosis of non-metastatic solid pancreatic lesions and particularly of adenocarcinomas with a slight advantage for mangafodipir trisodium-enhanced magnetic resonance imaging plus MR cholangiopancreatography.


Magnetic Resonance Imaging | 2010

Diffusion-weighted MRI in the characterization of cystic pancreatic lesions: usefulness of ADC values

Piero Boraschi; Francescamaria Donati; R Gigoni; S Salemi; Carlo Bartolozzi; Fabio Falaschi


Archive | 2010

MRI versus 18F-FDG PET/CT in the differential diagnosis of benign and malignant lesions of the pancreas

A Giorgetti; S Salemi; Piero Boraschi; Francescamaria Donati; R Gigoni; M Del Chiaro; Daniela Campani; Ugo Boggi; Fabio Falaschi; P. Marzullo


Journal of the Pancreas | 2008

Evaluation of Intraductal Papillary Mucinous Tumors with Secretin-Stimulated MR Pancreatography

Francescamaria Donati; Piero Boraschi; S Salemi; R Gigoni; M Del Chiaro; Ugo Boggi; Franco Mosca; Carlo Bartolozzi; Fabio Falaschi


AISP 32 National Congress | 2008

MR IMAGING VERSUS PET-CT IN THE DIFFERENTIAL DIAGNOSIS OF FOCAL PANCREATIC LESIONS

S Salemi; Piero Boraschi; Francescamaria Donati; R Gigoni; A Giorgetti; M Del Chiaro; Daniela Campani; Ugo Boggi; Fabio Falaschi


Journal of the Pancreas | 2007

Cystic Lesions of the Pancreas: Evaluation with MR Imaging and MR Pancreatography

S Salemi; Piero Boraschi; Francescamaria Donati; R Gigoni; Mc Cossu; M Del Chiaro; Ugo Boggi; Franco Mosca; Fabio Falaschi; Carlo Bartolozzi

Collaboration


Dive into the S Salemi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge